NervGen Pharma Appoints Michael Kelly as President & Chief Executive Officer
VANCOUVER, BC — NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF)(“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage,… Read More




